Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 1 · 25%Low 2 · 50%Moderate 1 · 25%High 0 · 0%

Menstrual blood loss: improvement rates · women with heavy menstrual bleeding

Antifibrinolytics may leads to higher menstrual blood loss: improvement rates compared with NSAIDs (low certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 1.43 [1.18, 1.74]
2 studies · 161 participants
Low

Menstrual blood loss: improvement rates · women with heavy menstrual bleeding

It is very uncertain whether antifibrinolytics changes menstrual blood loss: improvement rates compared with ethamsylate (very low certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 1.56 [0.95, 2.55]
1 study · 53 participants
Very low

Menstrual blood loss: improvement rates · women with heavy menstrual bleeding

Antifibrinolytics probably leads to higher menstrual blood loss: improvement rates compared with no treatment or placebo (moderate certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 3.34 [1.84, 6.09]
3 studies · 271 participants
Moderate

Menstrual blood loss: improvement rates · women with heavy menstrual bleeding

Antifibrinolytics may leads to higher menstrual blood loss: improvement rates (overall) compared with progestogens (low certainty).

1 finding from 1 review

Antifibrinolytics for heavy menstrual bleeding 2018 · Cochrane Headline outcomes only
RR 1.54 [1.31, 1.8]
5 studies · 422 participants
Low